Lataa...
A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML
Acute myeloid leukemia (AML) is one of the most common hematological malignancies. It is difficult to treat since it easily develops resistance to therapeutic drugs. Myeloid cell leukemia 1 (MCL-1), BCL-2 and BCL-XL, which belong to the anti-apoptotic group of proteins in the BCL-2 family, are overe...
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781566/ https://ncbi.nlm.nih.gov/pubmed/31612056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10891 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|